Built in 1902 to house an eccentric inventor’s rare plant collection, preserving this building in San Francisco has been a ...

What emerged through such discussions was not optimism nor was it pessimism, but clarity. The consensus was striking in its ...

In this podcast, Motley Fool analysts Karl Thiel, Tom King, and Tim Beyers discuss: Slow rolling chaos at the FDA and its effects on drug approvals. How to think about risk when investing in biotech.

Get the latest federal technology news delivered to your inbox. The congressional working group on the national security ramifications of biotechnology is angling to publish and deliver new policy ...

The beauty industry has long harnessed biotechnology — namely taking the most powerful skincare ingredients in nature and recreating them using science to make them more potent, stable, ...

Recognition underscores ValGenesis’ pioneering leadership and continued innovation in digital validation and AI-enabled lifecycle management. ValGenesis, the market leader in enterprise validation ...

This exclusive Cogs of War interview is with Diane DiEuliis, a distinguished research fellow at National Defense University focused on emerging biological technologies, biodefense, and preparedness ...

BioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible, and actionable for investors. The platform focuses on late-stage ...

BASKING RIDGE, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.